ATXS

Astria Therapeutics, Inc.

9.00 USD
+0.03 (+0.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Astria Therapeutics, Inc. stock is down -1.96% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 8 May’s closed higher than April. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
01 Apr 16:38 19 Apr, 2024 17.50 CALL 1182 5484

About Astria Therapeutics, Inc.

Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema.

  • Oppenheimer
    Tue May 21, 08:01
    buy
    confirm
  • HC Wainwright & Co.
    Fri May 10, 14:59
    buy
    confirm
  • Wedbush
    Fri May 10, 09:34
    buy
    confirm